Diabetes and obesity: leveraging heterogeneity for precision medicine
Franks PW, Sargent JL
Eur Heart J. 2024:ehae746.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomes
Riley DR, Henney A, Anson M, et al.
Diabetes Obes Metab. Pub. online 11 Nov 2024.
Leggi
Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction
Chimura M, Wang X, Jhund PS, et al.
JAMA Cardiol. 2024:e244613.
Leggi
Tirzepatide for obesity treatment and diabetes prevention
Jastreboff AM, le Roux CW, Stefanski A, et al.
N Engl J Med. Pub. online 13 Nov 2024.
Leggi
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
Zhou B, Rayner AW, Gregge EW, et al.
Lancet. 2024:S0140-6736(24)02317-1.
Leggi
Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes
Rooney MR, Wallace AS, Echouffo Tcheugui JB, et al.
Diabetologia. Pub. online 12 Nov 2024.
Leggi
Income-related disparities in mortality among young adults with type 2 diabetes
Kim JY, Park S, Park M, et al.
JAMA Netw Open. 2024;7(11):e2443918.
Leggi
The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices
Phillips NE, Mareschal J, Biancolin AD, et al.
Diabetologia. Pub. online 12 Nov 2024.
Leggi
Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
Baronti W, Lencioni C, Occhipinti M, et al.
Diabetes Res Clin Pract. 2024:111928.
Leggi
Effects of different types of intermittent fasting on metabolic outcomes: an umbrella review and network meta-analysis
Chen YE, Tsai HL, Tu YK, Chen LW
BMC Med. 2024;22(1):529.
Leggi